Patents by Inventor Rolf E. Streeck

Rolf E. Streeck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions
    Patent number: 7063963
    Abstract: The invention concerns DNA fragments derived from the genomic DNA of HPV-33. These fragments are selected from the group of fragments extending between the nucleotide extremities defined hereafter in relation to the nucleotide-numbering in FIGS. 1a and 1b respectively: 76–556 543–864 867–2811 2728–3808 3326–3575 3842–4079 4198–5611 5516–8091. The invention also relates to the use of these fragments as probes for the detection of HPV in tissue cultures.
    Type: Grant
    Filed: October 22, 2003
    Date of Patent: June 20, 2006
    Assignee: ROche Molecular Systems, Inc.
    Inventors: Stewart Cole, Rolf E. Streeck
  • Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions
    Publication number: 20040132012
    Abstract: The invention concerns DNA fragments derived from the genomic DNA of HPV-33. These fragments are selected from the group of fragments extending between the nucleotide extremities defined hereafter in relation to the nucleotide-numbering in FIGS.
    Type: Application
    Filed: October 22, 2003
    Publication date: July 8, 2004
    Inventors: Stewart Cole, Rolf E. Streeck
  • Determined DNA sequenced derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions
    Patent number: 6344314
    Abstract: The invention concerns DNA fragments derived from the genomic DNA of HPV-33. These fragments are selected from the group of fragments extending between the nucleotide extremities defined hereafter in relation to the nucleotide-numbering in FIGS. 1a and 1b respectively: 76-556 543-864 867-2811 2728-3808 3326-3575 3842-4079 4198-5611 5516-8091 The invention also relates to the use of these fragments as probes for the detection of HPV in tissue cultures.
    Type: Grant
    Filed: April 12, 2001
    Date of Patent: February 5, 2002
    Assignee: Institut Pasteur
    Inventors: Stewart Cole, Rolf E. Streeck
  • Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions
    Publication number: 20010049137
    Abstract: The invention concerns DNA fragments derived from the genomic DNA of HPV-33. These fragments are selected from the group of fragments extending between the nucleotide extremities defined hereafter in relation to the nucleotide-numbering in FIGS.
    Type: Application
    Filed: April 12, 2001
    Publication date: December 6, 2001
    Applicant: INSTITUT PASTEUR
    Inventors: Stewart Cole, Rolf E. Streeck
  • Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions
    Patent number: 6242250
    Abstract: The invention concerns DNA fragments derived from the genomic DNA of HPV-33. These fragments are selected from the group of fragments extending between the nucleotide extremities defined hereafter in relation to the nucleotide-numbering in FIGS. 1a and 1b respectively: 76-556 543-864 867-2811 2728-3808 3326-3575 3842-4079 4198-5611 5516-8091. The invention also relates to the use of these fragments as probes for the detection of HPV in tissue cultures.
    Type: Grant
    Filed: May 25, 2000
    Date of Patent: June 5, 2001
    Assignee: Institut Pasteur
    Inventors: Stewart Cole, Rolf E. Streeck
  • Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions
    Patent number: 6107086
    Abstract: The invention concerns DNA fragments derived from the genomic DNA of HPV-33. These fragments are selected from the group of fragments extending between the nucleotide extremities defined hereafter in relation to the nucleotide-numbering in FIGS. 1a and 1b respectively:76-556543-864867-28112728-38083326-35753842-40794198-56115516-8091.The invention also relates to the use of these fragments as probes for the detection of HPV in tissue cultures.
    Type: Grant
    Filed: June 11, 1999
    Date of Patent: August 22, 2000
    Assignee: Institut Pasteur
    Inventors: Stewart Cole, Rolf E. Streeck
  • Vectors for transforming CHO cells
    Patent number: 6051426
    Abstract: The invention concerns a composition useful for the manufacture of vaccines containing particles having the immunogenic properties characteristic of the antigen HBsAg, these particles being more particularly characterized by the fact that the particles equally contain a receptor for polymerized human albumin. They are obtained by transformation of human or animal cells by a vector containing a DNA sequence coding for the S and pre-S regions of a genome of viral hepatitis B, this DNA sequence being placed under the direct control of a promoter permitting the effective transcription of the sequence in the human or animal cells transformable by the vector.
    Type: Grant
    Filed: February 6, 1995
    Date of Patent: April 18, 2000
    Assignee: Institut Pasteur, Institut National de la Sante et de la Recherche Medicale and Centre National de la Recherche Scientifique
    Inventors: Elaine Sobczak, Yves Malpiece, deceased, Marie-Louise Michel, Pierre Tiollais, Rolf E. Streeck
  • Purified human papillomavirus type 33 (HPV-33) peptides as an immunogenic composition
    Patent number: 5876723
    Abstract: The invention concerns DNA fragments derived from the genomic DNA of HPV-33. These fragments are selected from the group of fragments extending between the nucleotide extremities defined hereafter in relation to the nucleotide-numbering in FIGS. 1a and 1b respectively76-556543-864867-28112728-38083326-35753842-40794198-56115516-8091.The invention also relates to the use of these fragments as probes for the detection of HPV in tissue cultures.
    Type: Grant
    Filed: July 15, 1997
    Date of Patent: March 2, 1999
    Assignee: Institut Pasteur
    Inventors: Stewart Cole, Rolf E. Streeck
  • Polypeptides encoded by DNA sequences derived from the genome of the papillomavirus HPV39, antibodies thereto, and their use in in vitro diagnosis
    Patent number: 5665535
    Abstract: Polypeptides encoded by genes of papillomavirus HPV39 are provided. Also provided are antibodies directed to the polypeptides, and methods for diagnosing genital neoplasias and for detecting infection by HPV39.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: September 9, 1997
    Assignees: Institut National de la Sante et de la Recherche Medicale, Institut Pasteur
    Inventors: Gerard Orth, Christoph Volpers, Rolf E. Streeck
  • DNA sequences derived from the genome of the papillomavirus HPV39, their use in in vitro diagnosis and for the production of an immunogenic composition
    Patent number: 5656423
    Abstract: Specific DNA sequences derived from the genome of papillomavirus HPV 39 are provided. Also provided are hybridization probes, and methods for diagnosing genital neoplasias and for detecting infection by HPV 39.
    Type: Grant
    Filed: November 16, 1993
    Date of Patent: August 12, 1997
    Assignees: Institut Pasteur, Institut National de la Sante et de la Recherche Medicale
    Inventors: Gerard Orth, Christoph Volpers, Rolf E. Streeck
  • Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions
    Patent number: 5648459
    Abstract: The invention concerns DNA fragments derived from the genomic DNA of HPV-33. These fragments are selected from the group of fragments extending between the nucleotide extremities defined hereafter in relation to the nucleotide-numbering in FIGS. 1a and 1b respectively:76-556543-864867-28112728-38083326-35753842-40794198-56115516-8091.The invention also relates to the use of these fragments as probes for the detection of HPV in tissue cultures.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: July 15, 1997
    Assignee: Institut Pasteur
    Inventors: Stewart Cole, Rolf E. Streeck
  • DNA sequences derived from papillomavirus HPV-33 genome
    Patent number: 5554538
    Abstract: The invention concerns DNA fragments derived from the genomic DNA of HPV-33. These fragments are selected from the group of fragments extending between the nucleotide extremities defined hereafter in relation to the nucleotide-numbering in FIGS. 1a and 1b respectively:______________________________________ 76-556 543-864 867-2811 2728-3808 3326-3575 3842-4079 4198-5611 5516-8091. ______________________________________The invention also relates to the use of these fragments as probes for the detection of HPV in tissue cultures.
    Type: Grant
    Filed: March 25, 1994
    Date of Patent: September 10, 1996
    Assignee: Institut Pasteur
    Inventors: Stewart Cole, Rolf E. Streeck
  • Composition useful for the fabrication of vaccines
    Patent number: 5324513
    Abstract: The invention concerns a composition useful for the manufacture of vaccines containing particles having the immunogenic properties characteristic of the antigen HBsAg, these particles being more particularly characterized by the fact that the said particles equally contain a receptor for polymerized human albumin. They are obtained by transformation of human or animal cells by a vector containing a DNA sequence coding for the S and pre-S regions of a genome of viral hepatitis B, this DNA sequence being placed under the direct control of a promoter permitting the effective transcription of the said sequence in the human or animal cells transformable by the said vector.
    Type: Grant
    Filed: February 28, 1991
    Date of Patent: June 28, 1994
    Assignees: Institut Pasteur, Institut National De La Sante Et De La Rocherche Medicale, Centre National De La Recherche Scientifique
    Inventors: Eliane Sobczak, Yves Malpiece, deceased, Marie-Louise Michel, Pierre Tiollais, Rolf E. Streeck